Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

Home/Academy/Journal Finder/American Journal of Clinical Oncology

Oncology

American Journal of Clinical Oncology

Wolters Kluwer (Lippincott Williams & Wilkins)

Multidisciplinary clinical oncology for cancer surgeons, radiation oncologists, medical oncologists, gynecologic oncologists and pediatric oncologists, with priority for combined-modality management of cancer

ISSN 0277-3732 (print)ISSN 1537-453X (online)Licence Open-access articles: CC BY-NC-ND; CC BY for authors with approved funders that require itAccess Hybrid (subscription, with optional open access)
Hybrid (subscription, with optional open access)Publishing model
Verified 2026-11Field-level — see each tab
CiteScore2.7 2025 · Scopus, via MOST Wiedzy and Journal Searches
Impact Factor1.8 2025 · JCR (Clarivate), via Wolters Kluwer Ovid
QuartileQ3 2025 · SCImago
Article Fee (APC)About $3,160 (optional OA) read Nov 2026 · SCImago listing, estimate
First DecisionNot disclosed by publisher
Acceptance RateNot disclosed by publisher

Overview

American Journal of Clinical Oncology is published by Wolters Kluwer (Lippincott Williams & Wilkins). Multidisciplinary clinical oncology for cancer surgeons, radiation oncologists, medical oncologists, gynecologic oncologists and pediatric oncologists, with priority for combined-modality management of cancer

Key information

PublisherWolters Kluwer (Lippincott Williams & Wilkins)
ISSN (Print)0277-3732
ISSN (Online)1537-453X
Publishing modelHybrid (subscription, with optional open access)
CountryUnited States
FrequencyMonthly (12 issues a year; print and online)
Subject categoryMedicine: Oncology; Biochemistry, Genetics and Molecular Biology: Cancer Research (SCImago)
EditorDavid E. Wazer, MD
Established1982
SubmissionsNot disclosed by the journal; SCImago records 129 documents published in 2025

ISSNs, NLM abbreviation, start year and MEDLINE status are from the NLM Catalog (NLM ID 8207754). Editor-in-Chief, frequency, format and readership as listed on Wolters Kluwer’s Ovid pages and the 2027 Lippincott media kit.

Aims & scope

AJCO gives priority to high-quality research on the combined-modality, multidisciplinary management of cancer. It also seeks to highlight:

  • Combined-modality, multidisciplinary cancer management
  • Translational research
  • Outcome studies
  • Cancer-related health policy
  • Cost-utility analyses
  • Selected opinion pieces and review articles

Case reports are not considered for publication.

Verified against the NLM Catalog record (ISSNs, abbreviation, start year, MEDLINE status), the journal’s Instructions for Authors (edmgr.ovid.com/ajco), Wolters Kluwer’s product pages and PubMed records for the sample articles.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.